(Q43175189)

English

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity

scientific article published on 7 November 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 November 2017

A novel CD46 mutation in a patient with microangiopathy clinically resembling thrombotic thrombocytopenic purpura and normal ADAMTS13 activity (English)

1 reference

Europe PubMed Central

15 November 2017

thrombocytopenia

1 reference

based on heuristic

inferred from title

thrombotic thrombocytopenic purpura

1 reference

based on heuristic

inferred from title

8

1 reference

Europe PubMed Central

15 November 2017

9

1 reference

Europe PubMed Central

15 November 2017

Gianluigi Ardissino

6

object named as

Gianluigi Ardissino

1 reference

Europe PubMed Central

15 November 2017

author name string

Raffaella Rossio

1

1 reference

Europe PubMed Central

15 November 2017

Luca Andrea Lotta

2

1 reference

Europe PubMed Central

15 November 2017

Silvia Pontiggia

3

1 reference

Europe PubMed Central

15 November 2017

Nicolò Ghiringhelli Borsa

4

1 reference

Europe PubMed Central

15 November 2017

Isabella Garagiola

5

1 reference

Europe PubMed Central

15 November 2017

Danijela Mikovic

7

1 reference

Europe PubMed Central

15 November 2017

publication date

7 November 2014

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

100

1 reference

Europe PubMed Central

15 November 2017

3

1 reference

Europe PubMed Central

15 November 2017

e87-9

1 reference

Europe PubMed Central

15 November 2017

Complement functional tests for monitoring eculizumab treatment in patients with atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Biomarkers of terminal complement activation confirm the diagnosis of aHUS and differentiate aHUS from TTP.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Atypical hemolytic uremic syndrome: from the rediscovery of complement to targeted therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

A phase 2 study of the safety and efficacy of rituximab with plasma exchange in acute acquired thrombotic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Atypical hemolytic-uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Implications of the initial mutations in membrane cofactor protein (MCP; CD46) leading to atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Genetic and functional analyses of membrane cofactor protein (CD46) mutations in atypical hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Clinical practice. Thrombotic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

von Willebrand factor cleaving protease (ADAMTS13) is deficient in recurrent and familial thrombotic thrombocytopenic purpura and hemolytic uremic syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Letter: Haemolytic-uraemic syndrome: evidence for intravascular C3 activation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4349284

25 May 2018

Thrombotic thrombocytopenic purpura and the hemolytic uremic syndrome: much progress and many remaining issues

1 reference

https://pubmed.ncbi.nlm.nih.gov/25381125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Initial experience from a double-blind, placebo-controlled, clinical outcome study of ARC1779 in patients with thrombotic thrombocytopenic purpura

1 reference

https://pubmed.ncbi.nlm.nih.gov/25381125

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3324/HAEMATOL.2014.111062

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

1 reference

Europe PubMed Central

15 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43175189&oldid=2046708350"